Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-24 @ 9:18 PM
NCT ID:
NCT06349304
Eligibility Criteria:
Inclusion Criteria:
1. Male and female participants, aged between 60 and 85 years old inclusive
2. English-literate and able to give informed consent in English
Exclusion Criteria:
1. Smokers
2. Allergy to grapes or food dyes/additives, or had serious food allergies in the past
3. Known eye diseases (macular degeneration, cataracts, retinopathy or glaucoma), blindness in at least one eye or have had eye surgery
4. Unable to view bright lights or flashing lights
5. Has Type 1 or 2 diabetes, uremia, cardiovascular disease, abnormal kidney and liver function
6. Taking eye medication and/or dietary supplements for the eyes for the past 3 month
7. Taking supplements containing carotenoids (e.g. Vitamin A, lutein, zeaxanthin) for past 3 months
8. Currently on a specialised diet (e.g. vegetarian, vegan, weight loss diet, low fat diet
9. Consumes more than 2 alcoholic drinks per day i.e. one drink is defined as either 150ml of wine,340ml of beer/cider or 45ml of distilled spirit
10. Significant change in weight (≥ 3 kg body weight) in the past 3 months
11. Significant exercise pattern over the past 3 months defined as high-intensity exercise of more than 3 hours per week
12. Currently on anti-hypertensive, cholesterol-lowering or psychoactive drugs
13. Scored ≤ 7 on the abbreviated mental test
14. Poor peripheral venous access based on past experiences with blood draw
15. Participating in another clinical study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
85 Years
Study:
NCT06349304
Study Brief:
Protocol Section:
NCT06349304